Remove tag healthcare-access
article thumbnail

Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)

Rethinking Clinical Trials

On March 21, 2020, in response to the COVID-19 pandemic, PCORI contacted leadership at Duke Clinical Research Institute and PCORnet and a decision was made to focus on the space of healthcare workers. Important issues early on included COVID-19’s effects on the workplace, vaccine access and willingness, and impact on home life.

Trials 130
article thumbnail

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Pharmaceutical Technology

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). The challenge of providing adequate access to the peripheral EU markets is quite evident. Europe’s forgotten territories.

Drugs 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin

Roots Analysis

It is worth noting that smart labels contain a transponder code which can be read by sophisticated devices, including radio frequency identification device (RFID) tags and near-field communication (NFC) chips. While most smartphones can read NFC chips, RFID tags can only be read by specialized receivers.

article thumbnail

Risk-sharing agreements are growing at a rate of 24%

Pharmaceutical Technology

This is not the first treatment to come with a high price tag. Partly in response to such drugs, risk-sharing agreements (RSAs) have increased in popularity and aim to mitigate the risks of including high-cost drugs on reimbursement lists and healthcare plans.

article thumbnail

Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

The Pharma Data

Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference | Johnson & Johnson. Johnson & Johnson to Participate in Goldman Sachs 42 nd Annual Global Healthcare Virtual Conference. Johnson & Johnson to Participate in Goldman Sachs 42 nd Annual Global Healthcare Virtual Conference.

article thumbnail

Johnson & Johnson to Participate in Wells Fargo 2020 Virtual Healthcare Conference

The Pharma Data

Johnson & Johnson to Participate in Wells Fargo 2020 Virtual Healthcare Conference | Johnson & Johnson. Johnson & Johnson to Participate in Wells Fargo 2020 Virtual Healthcare Conference. Johnson & Johnson to Participate in Wells Fargo 2020 Virtual Healthcare Conference. Learn More. Our Company. Eastern Time).

article thumbnail

Anti-Counterfeiting Technologies in Healthcare

Roots Analysis

In order to effectively combat the problems related to counterfeit medicines, several companies have come up with innovative technologies to provide the necessary tools to manufacturers, healthcare professionals and patients to authenticate pharmaceutical products.